• Thu. Apr 30th, 2026

Research

  • Home
  • SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer

Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to guide late-stage development of the SpyGlass Drug Delivery Platform ALISO VIEJO, Calif., March…

Rethinking life sciences research and innovation through integrated research campuses

Life sciences innovations have moved beyond isolated laboratories, and industry breakthroughs no longer depend solely on independent corporate R&D divisions. The focus has now swung to cohesive ecosystems where academia,…

Large-scale investment in research needed to maintain US agriculture

Climate change and flagging investment in research and development have U.S. agriculture facing its first productivity slowdown in decades. A new study by researchers at Stanford, Cornell, and the University…

INNOVATION SASKATCHEWAN INVESTS MORE THAN $1 MILLION IN RESEARCH AND DEVELOPMENT PROJECTS FOCUSED ON SUSTAINABLE TECHNOLOGIES-The Wakaw Recorder

Innovation Saskatchewan is investing $1.09 million in four industry-led research and development (R&D) technologies through the Saskatchewan Advantage Innovation Fund (SAIF) and Agtech Growth Fund (AGF). These dual R&D grant…

Abridge secures $250M for core research and development

Abridge, a generative AI platform for clinical conversations, announced it raised a $250 million Series D investment. The round was co-led by Elad Gil and IVP, with participation from Bessemer…

Research and Development | KGHM Corporate website

KGHM’s R&D activities are aimed at: developing new innovative solutions and technologies improving the efficiency of the KGHM Group, improving the safety of employees, increasing productivity at individual stages of…